In terms of new drugs that you can put out to the market, it's really more of a sti, more ofa jove. And then it is a long acting respiriton l a i that we hope to get approved next year. Is there a covet play for you guys? Not really, apart from the fact that we are distributing covet f accines in Israel. But we don't have a play specifically target towat ninge. Got about forty seconds, then we'll come back and talk some more. Hey, cor a few things we want to bounce around off of you,. I feel like, or out out out outlying issues, if you will
Teva CEO Kare Schultz on Earnings and Developing Generic Drugs. Bloomberg News Labor Reporter Josh Eidelson on Workers Press for Power in Rare Advance for U.S. Labor Movement. Bloomberg News Investing Reporter Annie Massa on Robinhood Sinks Below IPO Price as Revenue Misses Estimates. Bloomberg News Editor-at-Large Erik Schatzker on Hertz Teams With Uber, Carvana in Big Shift to Electric Cars. Drive to the Close with Barry James, President and Portfolio Manager at James Investment Research.
Hosted by Carol Massar and Tim Stenovec. Producer: Paul Brennan
See omnystudio.com/listener for privacy information.